Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 34 matching records.
34 results — page 1 of 2
- Level DLaboratory StudyPubMed
Priming-Dependent Modulation of Secretome in Placenta- and Adipose-Derived Mesenchymal Stromal/Stem Cells: Toward Cell-Free Immunoregenerative Therapies for Osteochondral and Degenerative Joint Diseases.
Laboratory Study on Osteoarthritis, Cartilage Damage, Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep - Level CProspective StudyPubMed
Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue-Derived Mesenchymal Stromal Cells (ASCs) and Interferon Gamma Priming for Enhanced Diabetic ASC-Based Therapy.
Prospective Study on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep - Level DLaboratory StudyPubMed
Characterization of Extracellular Vesicles from Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cells Expanded Using Regulatory-Compliant Media and Inflammatory/Hormonal Priming.
Laboratory Study on Osteoarthritis, Cartilage Damage, Chronic Inflammation, Immune Modulation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level DAnimal StudyPubMed
Differential effects of various cytokine priming on T-cell suppression and migration in canine mesenchymal stem cells.
Animal Study on Chronic Wound, Immune Modulation, published in Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cells - Level DLaboratory StudyPubMed
Priming Canine Adipose Tissue-Derived Mesenchymal Stem Cells with CBD-Rich Cannabis Extract Modulates Neurotrophic Factors Expression Profile.
Laboratory Study with a reported sample of 5 on Chronic Inflammation, Immune Modulation, published in Vet Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 5
Vet Sci - Level DLaboratory StudyPubMed
The optimized priming effect of FGF-1 and FGF-2 enhances preadipocyte lineage commitment in human adipose-derived mesenchymal stem cells.
Laboratory Study on Facial Rejuvenation, published in Genes Cells (2024) — summary generated from the PubMed abstract.
- 2024
Genes Cells4 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen
Narrative Review, published in Pharmaceuticals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Pharmaceuticals (Basel)2 citations - Level DLaboratory StudyPubMed
Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level DLaboratory StudyEurope PMC
Priming mesenchymal stem cells to develop "super stem cells"
Laboratory Study, published in World J Stem Cells (2024) — summary generated from the PubMed abstract.
- 2024
World J Stem Cells13 citations - Level DLaboratory StudyPubMed
The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.
Laboratory Study on Face & Skin, published in Biomolecules (2024) — summary generated from the PubMed abstract.
- 2024
Biomolecules2 citations - Level DLaboratory StudyPubMed
Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium.
Laboratory Study on Scar, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DAnimal StudyEurope PMC
Priming Mesenchymal Stem Cells with Lipopolysaccharide Boosts the Immunomodulatory and Regenerative Activity of Secreted Extracellular Vesicles
Animal Study with a reported sample of 8 on Chronic Inflammation, Immune Modulation, published in Pharmaceutics (2024) — summary generated from the PubMed abstract.
- 2024
- n = 8
Pharmaceutics9 citations - Level DLaboratory StudyPubMed
The roles of regulatory-compliant media and inflammatory/oxytocin priming selection in enhancing human mesenchymal stem/stromal cell immunomodulatory properties.
Laboratory Study on Osteoarthritis, Chronic Inflammation, Immune Modulation, published in Sci Rep (2024) — summary generated from the PubMed abstract.
- 2024
Sci Rep - Level BClinical TrialEurope PMC
Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use
Clinical Trial on Chronic Inflammation, published in World J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
World J Stem Cells37 citations - Level DAnimal StudyPubMed
The effect of poly I:C or LPS priming on the therapeutic efficacy of mesenchymal stem cells in an adjuvant-induced arthritis rat model.
Animal Study on Immune Modulation, Autoimmune Research, published in Pharmacol Rep (2022) — summary generated from the PubMed abstract.
- 2022
Pharmacol Rep - Level DAnimal StudyPubMed
Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling.
Animal Study on Autoimmune Research, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther - Level DLaboratory StudyPubMed
Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs- TRAIL) Increases Antitumor Efficacy of Their Secretome.
Laboratory Study on Systemic / IV, published in Curr Cancer Drug Targets (2021) — summary generated from the PubMed abstract.
- 2021
Curr Cancer Drug Targets - Level DAnimal StudyPubMed
Priming human adipose-derived mesenchymal stem cells for corneal surface regeneration.
Animal Study on Chronic Wound, Burns, Chronic Inflammation, published in J Cell Mol Med (2021) — summary generated from the PubMed abstract.
- 2021
J Cell Mol Med32 citations - Level DLaboratory StudyEurope PMC
Priming With Toll-Like Receptor 3 Agonist Poly(I:C) Enhances Content of Innate Immune Defense Proteins but Not MicroRNAs in Human Mesenchymal Stem Cell-Derived Extracellular Vesicles
Laboratory Study, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol29 citations - Level CProspective StudyEurope PMC
Therapeutic Effect of IL1β Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis
Prospective Study on Chronic Inflammation, Immune Modulation, published in Tissue Eng Regen Med (2021) — summary generated from the PubMed abstract.
- 2021
Tissue Eng Regen Med6 citations - Level BClinical TrialPubMed
Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells.
Clinical Trial on Systemic / IV, published in Elife (2021) — summary generated from the PubMed abstract.
- 2021
Elife - Level DLaboratory StudyPubMed
Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells.
Laboratory Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in BMC Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
BMC Dev Biol - Level DLaboratory StudyPubMed
Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
Laboratory Study on Osteoarthritis, Chronic Inflammation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther - Level DLaboratory StudyPubMed
Evaluation of Priming Efficiency of Forskolin in Tissue-Specific Human Mesenchymal Stem Cells into Dopaminergic Neurons: An In Vitro Comparative Study.
Laboratory Study, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406